TELO Telomir Pharma Yalpi foyda marjasi

TELO (Telomir Pharmaceuticals Corp) - kompaniyaning tovar belgisi

Telomir Pharmaceuticals (TELO) uzoq umr ko'rish sektorining ilmiy yondashuvga ega yosh ishtirokchisidir, garchi uning boshqaruv tuzilmasi hali shakllanish bosqichida bo'lsa-da. GURU.Markets xizmati tomonidan ushbu grafikda ko'rsatilgan haqiqiy yalpi foyda 0.00 ni tashkil etadi. Biznes molekulalar sintezini to'liq autsorsing qilishga tayanadi, bu esa kompaniyaga xodimlarning sonini kamaytirish va ma'muriy ofislarining ekologik izini minimallashtirish imkonini beradi.

Telomir Pharmaceuticals, Inc. (TELO): Yalpi marja 21.02.2024dan 20.11.2026gacha

Telomir Pharmaceuticals (TELO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:Telomir Pharmaceuticals, Inc. TELO
Telomir Pharmaceuticals Corp tomonidan chiqariladigan mahsulotlar

Yalpi marja bevosita ishlab chiqarish samaradorligini o'lchaydi va mahsulot yaratilishi bilan bog'liq barcha operatsion xarajatlar chegirilgandan keyingi foyda ulushini belgilaydi. Yalpi marja variansini tahlil qilish orqali investor Telomir Pharmaceuticals (TELO) tomonidan innovatsion qarishga qarshi terapevtik dori vositalarini ishlab chiqish jarayonida yashil kimyo tamoyillari va ESG standartlarini joriy etishning xomashyo xarajatlarini optimallashtirishga ta'sirini baholashi mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|ORMP - Yalpi foyda marjasi|Yalpi marja ENTX (Entera Bio)|Sotuvning yalpi marjinal rentabelligi MindWalk Therapeutics|ABVC: Yalpi foyda bo'yicha rentabellik|CPIX - Yalpi marja|QNTM (Quantum BioPharma) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik FGEN (FibroGen)|RANI (Rani Therapeutics Inc) - Yalpi marja|Yalpi foyda marjasi synergychc.com SNYR|Yalpi rentabellik Rallybio Corp. (RLYB)|LEXX - Yalpi foyda marjasi|Yalpi marja PULM (pulmatrix.com)|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja